TheraRadar
Data updated: May 26, 2026

hudquzco rubber panel,rubber panel t.r.u.e. test (rubber panel thin-layer rapid use epicutaneous patch test)

Approved 2017-03-02
1
Indication
--
Phase 3 Trials
9
Years on Market

Details

Status
Prescription
First Approved
2017-03-02
Routes
Topical
Dosage Forms
Patch

hudquzco rubber panel,rubber panel t.r.u.e. test Approval History

2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2017 to 2017
Mar 2017 ORIGINAL
Update · CBER biologic (Purple Book)

What hudquzco rubber panel,rubber panel t.r.u.e. test Treats

1 FDA approvals

Originally approved for its first indication in 2017 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

hudquzco rubber panel,rubber panel t.r.u.e. test FDA Label Details

Track hudquzco rubber panel,rubber panel t.r.u.e. test with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.